Daiken Biomedical Co., Ltd. (TPE:7780)
Taiwan · Delayed Price · Currency is TWD 17.90
+0.05 (0.28%)
At close: Jul 16, 2026
Daiken Biomedical Market Cap
Daiken Biomedical has a market cap or net worth of 14.5 billion as of July 16, 2026. Its market cap has decreased by -30.46% in one year.
Market Cap
14.50B
Enterprise Value
9.18B
Revenue
2.02B
Ranking
n/a
PE Ratio
38.21
Stock Price
17.90
ChartMarket Cap Chart
Since October 28, 2024, Daiken Biomedical's market cap has increased from 10.68B to 14.50B, an increase of 35.76%. That is a compound annual growth rate of 19.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 16, 2026 | 14.50B | -0.28% |
| Dec 31, 2025 | 14.54B | 33.88% |
| Dec 31, 2024 | 10.86B | 1.69% |
| Oct 28, 2024 | 10.68B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Standard Foods | 27.48B |
| Lian Hwa Foods | 27.43B |
| TTET Union | 25.92B |
| Ve Wong | 10.70B |
| Tehmag Foods | 9.60B |
| Microbio | 9.32B |
| Namchow Holdings | 8.35B |
| Taisun Enterprise | 8.12B |